CATALOGO DEI PRODOTTI DELLA RICERCA

CINGARLINI, Sara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.911
NA - Nord America 4.103
AS - Asia 2.880
SA - Sud America 411
AF - Africa 50
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.367
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.003
RU - Federazione Russa 1.971
CN - Cina 1.113
SG - Singapore 1.050
GB - Regno Unito 983
IT - Italia 459
BR - Brasile 333
SE - Svezia 324
DE - Germania 308
IE - Irlanda 264
HK - Hong Kong 252
FR - Francia 212
FI - Finlandia 166
VN - Vietnam 163
KR - Corea 59
CA - Canada 56
JP - Giappone 44
TR - Turchia 44
IN - India 40
NL - Olanda 40
UA - Ucraina 36
AR - Argentina 30
BE - Belgio 29
MX - Messico 28
ES - Italia 27
PL - Polonia 23
ID - Indonesia 22
AT - Austria 18
BD - Bangladesh 18
IR - Iran 15
ZA - Sudafrica 15
IQ - Iraq 14
AE - Emirati Arabi Uniti 10
VE - Venezuela 10
CL - Cile 9
LV - Lettonia 8
AU - Australia 7
EC - Ecuador 7
LT - Lituania 7
MA - Marocco 7
AZ - Azerbaigian 6
CH - Svizzera 6
CO - Colombia 6
EG - Egitto 6
PE - Perù 5
PH - Filippine 5
UY - Uruguay 5
BJ - Benin 4
CZ - Repubblica Ceca 4
JM - Giamaica 4
PY - Paraguay 4
TG - Togo 4
UZ - Uzbekistan 4
DZ - Algeria 3
IL - Israele 3
JO - Giordania 3
KE - Kenya 3
MK - Macedonia 3
PA - Panama 3
AL - Albania 2
BY - Bielorussia 2
CM - Camerun 2
DK - Danimarca 2
ET - Etiopia 2
GR - Grecia 2
HR - Croazia 2
KZ - Kazakistan 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
RO - Romania 2
SA - Arabia Saudita 2
SI - Slovenia 2
SN - Senegal 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BO - Bolivia 1
CR - Costa Rica 1
DM - Dominica 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
KW - Kuwait 1
MD - Moldavia 1
ME - Montenegro 1
MQ - Martinica 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
PW - Palau 1
QA - Qatar 1
RS - Serbia 1
Totale 12.364
Salva come PNG Salva come JPEG
Città #
Southend 866
Moscow 736
Chandler 614
Dallas 562
Singapore 534
Ashburn 363
Dublin 254
Hong Kong 246
Jacksonville 245
Beijing 226
Ann Arbor 214
Woodbridge 204
Verona 140
New York 134
Houston 95
Los Angeles 94
Munich 84
Jinan 76
Lawrence 76
Princeton 76
The Dalles 72
Wilmington 72
Shenyang 70
Ho Chi Minh City 63
Helsinki 60
Tianjin 55
São Paulo 54
Nanjing 53
Hebei 40
Tokyo 38
Changsha 35
Milan 35
Columbus 34
Haikou 34
Guangzhou 33
Redmond 32
Redondo Beach 31
Zhengzhou 31
Brussels 29
Santa Clara 29
Hanoi 27
Denver 26
Seattle 25
Bologna 24
London 24
Montreal 24
Sindelfingen 24
Buffalo 23
Nanchang 23
Taiyuan 23
Hangzhou 22
Seoul 22
Turku 22
Ningbo 20
Taizhou 20
Warsaw 20
Lancaster 19
Redwood City 19
Chicago 17
San Francisco 17
Falkenstein 16
Orem 16
Jiaxing 15
Brooklyn 14
Chennai 14
Shanghai 14
Kent 13
Phoenix 13
Poplar 13
Rio de Janeiro 13
Stockholm 13
Toronto 13
Amsterdam 12
Boardman 12
Council Bluffs 12
Dong Ket 12
Jakarta 12
Mexico City 12
Frankfurt am Main 11
Washington 11
Curitiba 10
Fuzhou 10
Johannesburg 10
San Jose 10
Brescia 9
Norwalk 9
Nuremberg 9
Rome 9
Atlanta 8
Belo Horizonte 8
Dearborn 8
Manchester 8
Lappeenranta 7
Mumbai 7
Ankara 6
Baghdad 6
Baku 6
Desenzano del Garda 6
Düsseldorf 6
Genova 6
Totale 7.599
Salva come PNG Salva come JPEG
Nome #
Whole-genome landscape of pancreatic neuroendocrine tumours 253
Anti-tumor effects of toxins targeted to the prostate specific membrane antigen. 248
Anti PSMA immunotoxins activity against prostate cancer cell lines. 247
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 222
Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? 214
Anti PSCA Monoclonal Antibody and scFv-Fragment for Immunotherapy of Prostate, Pancreatic and Bladder Carcinoma 211
Apical transport and folding of prostate-specific membrane antigen occurs independent of glycan processing. 210
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 209
3D-CT texture analysis of neuroendocrine pancreatic neoplasms 208
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 205
Characterization of a new anti PSCA monoclonal antibody and scFv fragment for diagnosis and immunotherapy of prostate, pancreatic and bladder carcinoma. 196
Perfusion Changes in Liver Metastases (LM) from Pancreatic Neuroendocrine Tumors (PanNETs) during Everolimus (E) Treatment: Update of Perfusion CT (P-CT) Study 194
A prospective non-randomised single-center study comparing laparoscopic and robotic distal pancreatectomy 192
Anticorpo monoclonale isolato o suo frammento legante l'antigene specifico di membrana della prostata, suoi coniugati e suoi usi 188
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 186
A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer 186
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 186
CT Enhancement and 3D Texture Analysis of Pancreatic Neuroendocrine Neoplasms 186
Anti-prostate specific membrane antigen targeted gold nanoparticles in tumor therapy and diagnosis 182
EpCAM a possible target for immunotoxin treatments of PSMA positive and negative prostate cancer cells 180
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 178
Ingegnerizzazione di un vettore per espressione di frammenti anticorpali (scFv) biotinilati in procarioti, purificazione ed analisi funzionale 174
Tumor Perfusion Changes During Everolimus (E) Treatment: Preliminary Results from Perfusion-CT (P-CT) Study 174
Adjuvant Chemotherapy For Resected Non-Small-Cell Lung Cancer: Future Perspectives For Clinical Research 173
The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumor cells by activating the MAPK pathways. 173
Production of a biotinylated anti-PSMA single-chain antibody fragment (scFv) for imaging and radioimmunotherapy 172
Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components 172
Investigation of Properties of Anti-Prostate Specific Membrane Antigen-targeted Gold Nanoparticles as Drug Carriers in Tumor Therapy 168
Tumor Targeting with Guided Silica Nanopartilces for Prostate Cancer Therapy 168
Dual-tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT scan and G1-G2 non-functioning pancreatic neuroendocrine tumors: A single-center retrospective evaluation of 124 non-metastatic resected cases 168
The prostate specific membrane antigen regulates the expression of IL-6 and CCL-5 in prostate tumour cells by activating the MAPK pathways 167
Role of Combined Ga-68-DOTATOC and F-18-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors Implications for Managing Surgical Decisions 167
Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage 167
Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment 166
Produzione e validazione preclinica di un anticorpo anti-PSMA per diagnostica ed immunotargeting 165
ESGAR 2016 Book of Abstracts 165
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 165
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 165
Liver Tumor Burden in Pancreatic Neuroendocrine Tumors: CT Features and Texture Analysis in the Prediction of Tumor Grade and 18F-FDG Uptake 162
Generazione di nuovi anticorpi anti prostate stem cell antigen (PSCA) e loro caratterizzazione al fine di un futuro utilizzo nella terapia e nella diagnosi dei carcinomi prostatico, pancreatico e della vescica 157
Prognostication and response assessment in liver and pancreatic tumors: The new imaging 155
The development of PARP as a successful target for cancer therapy 153
Pathological complete response in a patient affected by multiple synchronous, breast and lung primary malignancies: a case report and review of the literature 152
Tumor Perfusion Changes During Everolimus (E) Treatment: Preliminary Results from Perfusion-CT (P-CT) Study 145
Pancreatic neuroendocrine neoplasms: MRI features and correlation with their histological grade 141
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases 141
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 141
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 140
Digital Subtraction of Magnetic Resonance Images Improves Detection and Characterization of Pancreatic Neuroendocrine Neoplasms 140
Platinum-Based Treatment for Well- and Poorly Differentiated Pancreatic Neuroendocrine Neoplasms 140
Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors 139
Imaging presentation of pancreatic neuroendocrine neoplasms 138
Isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen, conjugates and uses thereof 136
Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? 136
Efficacy and Toxicity Analysis of mFOLFIRINOX in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms 133
Histogram analysis of ADC maps: assessment of intra-tumoral heterogeneity and correlation with the biological behavior of pancreatic neuroendocrine neoplasms 132
Prognostic Stratification and Therapeutic Response Assessment in Liver and Pancreatic Tumors: the New Imaging 131
Solid non-functioning endocrine tumors of the pancreas: correlating computed tomography and pathology 131
Clinical presentation, genotype-phenotype correlations, and outcome of pancreatic neuroendocrine tumors in Von Hippel-Lindau syndrome 127
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants 126
Streptozotocin/5-Fluorouracil (STZ/5FU) Chemotherapy in G1-G2 Pancreatic Neuroendocrine Tumors (pNETs): Single Institution Experience 125
Preclinical studies of a new anti-psma (prostate specific membrane antigen) antibody for diagnosis and immunotargeting 123
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association 122
Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology 119
Is Laparoscopic CME Right Hemicolectomy an Optimal Indication for NET of the Right Colon and Terminal Ileum? 117
Minimally Invasive Surgery for Pancreatic Neuroendocrine Tumors: Why Not? 115
Differentiation of pancreatic neuroendocrine tumor grade comparing 3D CT texture analysis and relative CT enhancement ratios 115
Surgery for pancreatic neuroendocrine tumors during the COVID-19 pandemic: a retrospective cohort from a high-volume center 114
Profiling mTOR pathway in neuroendocrine tumors 114
Suppression of mTOR pathway in solid tumors: lessons learned from clinical experience in renal cell carcinoma and neuroendocrine tumors and new perspectives 111
Ultra-Mutation in IDH Wild-Type Glioblastomas of Patients Younger than 55 Years is Associated with Defective Mismatch Repair, Microsatellite Instability, and Giant Cell Enrichment 110
Pancreatic Neuroendocrine Neoplasms: Clinical Value of Diffusion-Weighted Imaging 106
PSMA-Specific CAR-Engineered T Cells Eradicate Disseminated Prostate Cancer in Preclinical Models 105
Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring 101
Normal Tissue Perfusion Changes During Everolimus Treatment: Preliminary Results from a Functional Vascular Study 94
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size 87
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine 82
Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres) 80
Transcriptome analysis of primary sporadic neuroendocrine tumours of the intestine identified three different molecular subgroups 80
Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors 77
Somatostatin analogs for resectable pancreatic neuroendocrine tumors in high-risk surgical patients: Data from a single-center cohort 72
Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant? 65
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET) 35
Totale 12.515
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.986
article - articoli 27.894
book - libri 0
conference - conferenze 11.397
curatela - curatele 0
other - altro 449
patent - brevetti 871
selected - selezionate 0
volume - volumi 375
Totale 81.972
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021249 0 0 0 0 0 50 14 37 41 17 62 28
2021/2022786 65 256 18 70 37 17 14 44 23 18 53 171
2022/20231.625 96 211 148 287 108 429 38 88 173 9 25 13
2023/2024835 29 66 75 82 90 166 25 50 9 65 144 34
2024/20251.933 104 112 108 273 99 76 104 88 279 137 182 371
2025/20264.499 412 354 507 1.112 1.736 378 0 0 0 0 0 0
Totale 12.515